- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.03. | FDA gives Glenmark thumbs up for first 'true' generic version of GSK's asthma inhaler Flovent | ||
| 05.03. | After generic defense fails, Merck KGaA assumes no US Mavenclad sales after March | ||
| 05.03. | Galderma doubles Nemluvio peak sales projection to $4B-plus after strong atopic dermatitis launch year | ||
| 05.03. | Leo roars onto Netflix with DTC campaign for new hand eczema cream Anzupgo | ||
| 04.03. | Collegium enrolls Paris Hilton in Jornay PM push encouraging ADHD community to 'Embrace Your Sparkle' | ||
| 04.03. | FDA answers Vanda's yearslong call for public hearing on unsuccessful jet lag approval bid | ||
| 04.03. | CRDMO BioDuro enters Taiwan joint venture, adding commercial API plant to production network | ||
| 04.03. | Bayer looking at another year of 'resilience' before growth kicks in behind Nubeqa, Kerendia | ||
| 04.03. | Novo lands another FDA untitled letter, this time for Apple-inspired Ozempic ad | ||
| 04.03. | Moderna fronts $950M to settle yearslong COVID patent litigation with Genevant, Arbutus | ||
| 04.03. | Danish agency NoA Health names new CEO to drive global expansion | ||
| 03.03. | Pfizer CEO Albert Bourla on FDA official Prasad: 'We have a problem with the leadership of CBER' | ||
| 03.03. | Guardant picks Patrick Dempsey for colorectal cancer blood test awareness | ||
| 03.03. | Acadia, undaunted by recent EU rejection, seeks CHMP re-examination of Rett syndrome med Daybue | ||
| 03.03. | FDA's CRLs reveal critical errors in AstraZeneca's Saphnelo data, efficacy doubts for GSK's Exdensur | ||
| 03.03. | Disc lays off 20% of employees to steady ship after FDA rejection of rare disease drug | ||
| 03.03. | Novo plugs $500M into Ireland plant to produce Wegovy pill for markets outside US | ||
| 03.03. | Esperion pays $75M-plus to acquire Corstasis and newly approved Enbumyst | ||
| 02.03. | 'One2PrEP': Gilead's 1st Yeztugo DTC ad reimagines hit song to highlight biannual dosing | ||
| 02.03. | Regulatory tracker: Novo Nordisk, BioMarin gain FDA label expansions | ||
| 02.03. | Amid unfolding Middle East war, pharma giants keep close eye on employee safety, supply chains | ||
| 02.03. | Kennedy adds 2 new members to CDC's vaccine panel ahead of delayed meeting | ||
| 02.03. | CDMO Quotient extends Ipsen supply pact for rare disease drug Sohonos | ||
| 02.03. | Bavarian Nordic CEO to follow board chair out the door after failed private equity takeover | ||
| 02.03. | Ascendis gains more altitude with FDA approval for dwarfism drug Yuviwel |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.